Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Asset Utilization Ratio (2020 - 2025)

Addex Therapeutics' Asset Utilization Ratio history spans 6 years, with the latest figure at 0.01 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 66.15% to 0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01, a 66.15% decrease, with the full-year FY2025 number at 0.0, down 93.13% from a year prior.
  • Asset Utilization Ratio came in at 0.01 for Q4 2025, down from 0.02 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.33 in Q1 2024, with the low at 0.01 in Q4 2025.
  • Historically, Asset Utilization Ratio has averaged 0.15 across 5 years, with a median of 0.14 in 2021.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 147.26% in 2023 and later tumbled 88.09% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.14 in 2021, then dropped by 3.57% to 0.14 in 2022, then surged by 109.99% to 0.29 in 2023, then plummeted by 88.09% to 0.03 in 2024, then crashed by 66.15% to 0.01 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ADXN at 0.01 in Q4 2025, 0.02 in Q3 2025, and 0.03 in Q4 2024.